Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Science &
Statistics for life

America’s #1 source for science, data, and medical research on the value of human life.

Promoting deeper public understanding

More than 70 scholars are leveraging groundbreaking research to share science and statistics for life in the public square, in the courts and halls of power, and directly with the American people.

Latest Research and News

Keep up with the latest on our life-related research, public policy, and media.

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepristone is not "safe," that the FDA's loosening of mifepristone regulations makes these safety concerns even worse, and that AHM et al. have standing, since they would suffer concrete injury under the current loosened mifepristone regulations, being at risk of finding themselves complicit in abortion procedures.
charlotte-lozier-institute Charlotte Lozier Institute
March 21, 2024
ClosePlease login
Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case

Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case

CLI recently filed an amicus brief in the case Moyle v. United States (consolidated with Idaho v. U.S.) to be considered before the Supreme Court this April. The Biden administration has interpreted the federal Emergency Medical Treatment and Labor Act in a way that would compel emergency room doctors to perform abortions even when a mother’s life is not in danger. According to CLI, such an interpretation of EMTALA is incoherent and in conflict with the plain sense of the text.

charlotte-lozier-institute Charlotte Lozier Institute
March 25, 2024
ClosePlease login
Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data

Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data

The FDA’s abortion drugs complications data is woefully incomplete. From 2020-2022, the six states that report complications by type of procedure reported 1,004 total complications from drug-induced abortions. Meanwhile, the FDA Adverse Event Reporting System data reflects just 17 unduplicated abortion-related adverse events over this same period.

CLI Authors’ Responses to Sage Concerns and Retractions

CLI Authors’ Responses to Sage Concerns and Retractions

On February 5, 2024, Sage Publications retracted three peer-reviewed articles authored by affiliates of the Charlotte Lozier Institute. Prior to these retractions, Sage issued an expression of concern against the first of the three articles in July of 2023. Reproduced here are the authors’ initial response to Sage’s notice informing CLI of its intention to issue an expression of concern, as well as the authors’ subsequent response to the official retractions.

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Latest Videos

More Videos

Chemical Abortion – Elizabeth’s Story

January 24, 2024

In a world where abortion drugs can be ordered through the mail and states like Washington, California, New York, and Massachusetts are stockpiling mifepristone and misoprostol, Elizabeth Gillette wants women to know the truth.

Tara Sander Lee | “Knit Together in a Mother’s Womb”

August 13, 2023

Dr. Tara Sander Lee, molecular and cellular biologist at the Charlotte Lozier Institute, shares her firsthand testimony of studying the wonders of human genetics and reproduction as designed by God.

Do pro-life laws actually prevent doctors from providing care to women?

February 7, 2023

Dr. Ingrid Skop, Vice President and Director of Medical Affairs for Charlotte Lozier Institute, answers the question, "Do pro-life laws actually prevent doctors from providing care to women?"

Current Lozier Institute Initiatives

Lozier Institute’s array of interactive resources are designed to inform and empower the public, educate and equip leaders, and re-frame the debate on the full spectrum of life issues.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image